Home › Forums › Valdig.eu website › Prophylaxis of SOS in patient with vascular liver disease › Reply To: Prophylaxis of SOS in patient with vascular liver disease
6 May 2021 at 16h58 #2754
Andrea De Gottardi
For the preparation of the VALDIG book that will include a chapter dedicated to this issue, Prof. Paul Richardson was rather supporting the use of DF in this indication. Prevention should be considered in particular in subjects at high risk with UDCA and DF, but data available refer to a limited numnber of patients and therefore need to be confirmed.